Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,99 NOK | +1,14% | -20,44% | -93,57% |
Omzet 2024 * | 954 mln. 86,78 mln. 81,48 mln. | Omzet 2025 * | - | Marktkapitalisatie | 272 mln. 24,74 mln. 23,23 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 654 mln. 59,52 mln. 55,89 mln. | Nettowinst (verlies) 2025 * | -140 mln. -12,74 mln. -11,96 mln. | EV/omzet 2024 * | -0,95 x |
Nettoliquiditeiten 2024 * | 1,18 mld. 107 mln. 101 mln. | Nettoliquiditeiten 2025 * | 1,05 mld. 95,52 mln. 89,69 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
0,48
x | K/w-verhouding 2025 * |
-2,07
x | Werknemers | 26 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 68,97% |
Recentste transcriptie over Ultimovacs ASA
1 dag | -4,93% | ||
1 week | -20,44% | ||
Lopende maand | -0,88% | ||
1 maand | +1,28% | ||
3 maanden | -94,24% | ||
6 maanden | -94,65% | ||
Lopend jaar | -93,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Carlos de Sousa
CEO | Chief Executive Officer | 66 | 01-06-20 |
Director of Finance/CFO | 57 | - | |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jónas Einarsson
CHM | Chairman | 67 | 26-01-11 |
Henrik Schüssler
BRD | Director/Board Member | 61 | 01-01-15 |
Kari Grønås
BRD | Director/Board Member | 59 | 01-01-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 7,99 | +1,14% | 12 481 |
22-04-24 | 7,9 | -4,93% | 261 462 |
19-04-24 | 8,31 | -0,60% | 574 668 |
18-04-24 | 8,36 | -4,46% | 897 326 |
17-04-24 | 8,75 | -13,37% | 2 863 735 |
Real Time Oslo Bors, 23 april 2024 om 09:01 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-93,57% | 24,64 mln. | |
-0,02% | 42,11 mld. | |
+43,29% | 40,08 mld. | |
+5,04% | 40 mld. | |
-11,32% | 26,87 mld. | |
+5,25% | 24,58 mld. | |
-23,83% | 18,44 mld. | |
-1,62% | 11,94 mld. | |
+22,75% | 11,66 mld. | |
+6,44% | 11,01 mld. |